Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) May Be an Alternative Preventive Therapy in Children with Cerebral Palsy

• Published in: Oral health & preventive dentistry Vol. 13; no. 5; p. 441
• Main Authors: Özdas, Didem Öner, Tuna, Elif Bahar, Yilmaz, Esra Yamac, Aytepe, Zeynep
• Format: Journal Article
• Language: English
• Published: Germany 2015
• Subjects: Beverages - classification; Buffers; Cariostatic Agents - therapeutic use; Caseins - therapeutic use; Cerebral Palsy - complications; Child; Child, Preschool; Dental Caries - prevention & control; Dental Plaque - physiopathology; Dentition, Mixed; Feeding Behavior; Female; Follow-Up Studies; Humans; Hydrogen-Ion Concentration; Male; Saliva - physiology; Tooth, Deciduous - drug effects

To evaluate the effect of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) on the buffering capacity of saliva and plaque pH in individuals with cerebral palsy (CP). A total of 15 3- to 8-year-old subjects with CP living in a governmental institution were included in this study. Dental pl...